Abstract
A large-scale procedure for purification and concentration of Japanese encephalitis virus vaccine by a continuous-flow isopycnic banding technique in a sucrose density gradient solution, using a K-III zonal centrifuge rotor, is presented. The quality of zonal-purified vaccine was compared with commercial and Japanese National Institutes of Health reference vaccines for antigenicity, immunodiffusion, and allergic encephalitogenicity tests to show its high purity.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson N. G., Waters D. A., Nunley C. E., Gibson R. F., Schilling R. M., Denny E. C., Cline G. B., Babelay E. F., Perardi T. E. K-series centrifuges. I. Development of the K-II continuous-sample-flow-with-banding centrifuge system for vaccine purification. Anal Biochem. 1969 Dec;32(3):460–494. doi: 10.1016/s0003-2697(69)80014-x. [DOI] [PubMed] [Google Scholar]
- CLARKE D. H., CASALS J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg. 1958 Sep;7(5):561–573. doi: 10.4269/ajtmh.1958.7.561. [DOI] [PubMed] [Google Scholar]
- Darwish M. A., Hammon W. M. Studies on Japanese B encephalitis virus vaccines from tissue culture. VI. Development of a hamster kidney tissue culture inactivated vaccine for man. 3. Potency testing of an attenuated strain of OCT-541. J Immunol. 1966 May;96(5):878–884. [PubMed] [Google Scholar]
- Eylar E. H., Salk J., Beveridge G. C., Brown L. V. Experimental allergic encephalomyelitis. An encephalitogenic basic protein from bovine myelin. Arch Biochem Biophys. 1969 Jun;132(1):34–48. doi: 10.1016/0003-9861(69)90336-1. [DOI] [PubMed] [Google Scholar]
- Gerin J. L., Anderson N. G. Purification of influenza virus in the K-II zonal centrifuge. Nature. 1969 Mar 29;221(5187):1255–1256. doi: 10.1038/2211255a0. [DOI] [PubMed] [Google Scholar]
- Hammon W. M., Darwish M. A., Rhim J. S., Sather G. E., Yohn D. S., Mittelman A., Deverson E., Soyka J. P. Studies on Japanese B encephalitis virus vaccines from tissue culture. V. Response of man to live, antenuated strain of OCT-541 virus vaccine. J Immunol. 1966 Mar;96(3):518–524. [PubMed] [Google Scholar]
- KITOAKA M., NISHIMURA C. Noninfectious hemagglutinin and complement-fixing antigen of Japanese B encephalitis. Virology. 1963 Feb;19:238–239. doi: 10.1016/0042-6822(63)90014-x. [DOI] [PubMed] [Google Scholar]
- Oshiro Y., Eylar E. H. Allergic encephalomyelitis: a comparison of the encephalitogenic A1 protein from human and bovine brain. Arch Biochem Biophys. 1970 Jun;138(2):606–613. doi: 10.1016/0003-9861(70)90387-5. [DOI] [PubMed] [Google Scholar]
- Shapiro D., Brandt W. E., Cardiff R. D., Russell P. K. The proteins of Japanese encephalitis virus. Virology. 1971 Apr;44(1):108–124. doi: 10.1016/0042-6822(71)90158-9. [DOI] [PubMed] [Google Scholar]
- Singh B., Chang I. C., Hammon W. M. Semi-commercial-scale production of Japanese B encephalitis virus vaccines from tissue culture. Appl Microbiol. 1973 Jun;25(6):945–951. doi: 10.1128/am.25.6.945-951.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]